Page 1 of 3
123

2025 (5 POSTS)

Verwiel A, Rish W. Importance of integrating cumulative chemical exposures into cumulative impact assessment for vulnerable communities. Session T1-A, Society for Risk Analysis (SRA) Annual Meeting, Washington, DC, December 2025.

View Abstract

Franke K, Panko J, Hidding B, DeLee M, Davis CW, Norman J. Development of a database for identification, hazard assessment and risk assessment support for plastic additives in commerce. Abstract 7.04.P-Tu-126, SETAC North America 46th Annual Meeting, Portland, OR, November 2025.

View Abstract

Rish W, Verwiel A. Importance of epidemiology and visualization to integrate non-chemical stressors into cumulative impact assessment for vulnerable communities. Abstract 568/Poster P47-17, International Society of Exposure Science and International Society for Environmental Epidemiology (ISES/ISEE) Joint Annual Meeting, Atlanta, GA, August 2025.

View Abstract

Diemar MG, Giusti A, Michel-Caillet C, Leme DM, Wikoff D, Bloch D, Sass J, Beekmann K, et al. 2025. How to organize a successful toxicology workshop? A participant perspective on the Collaboration to Harmonise the Assessment of Next Generation Evidence (CHANGE) workshop in Oslo, 18-20 June 2024. Arch Toxicol 99(7):3057-3063; doi: 10.1007/s00204-025-04064-6. PMID: 40372420.

View Abstract

Jacobellis M, Garcia M, Bain L, Pearce J, Hunt K, Baldwin W. Disruption of energy homeostasis by chemical mixtures containing persistent pollutants in HepG2 and C2C12 cells. Abstract 4564, Society of Toxicology 64th Annual Meeting, Orlando, FL, March 2025.

View Abstract

2024 (1 POST)

Franke K, Vincent M, Rogers S, Rivera B, Wikoff D. Assessment of non-occupational exposures to cleaning products and the incidence of asthma and respiratory disease. Abstract 3393, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.

View Abstract

2023 (2 POSTS)

Nyffeler J, Willis C, Harris FR, Foster MJ, Chambers B, Culbreth M, Brockway RE,…, Patlewicz G, et al. 2023. Application of cell painting for chemical hazard evaluation in support of screening-level chemical assessments. Toxicol Appl Pharmacol 468(June 1):116513; doi: 10.1016/j.taap.2023.116513. PMID: 37044265.

View Abstract

Houck K, Paul Friedman K, Feshuk M, Patlewicz G, Smeltz M, Clifton S, Wetmore BA, Velichko S, et al. 2023. Evaluation of 147 perfluoroalkyl substances for immunotoxic and other (patho)physiological activities through phenotypic screening of human primary cells. ALTEX 40(2):248–270; doi: 10.14573/altex.220304. PMID: 36129398.

View Abstract

2022 (2 POSTS)

Hoffmann S, Aiassa E, Angrish M, Beausoleil C, Bois FY… Wikoff D, et al. 2022. Application of evidence-based methods to construct mechanism-driven chemical assessment frameworks. ALTEX 39(3):499-518; doi: 10.14573/altex.2202141. PMID: 35258090.

View Abstract

Vincent M, O’Neill HC, Maier A, Buerger AN, Madl AK. Analysis of toxicity assay options for data poor chemical inhalation limit setting: Flavors as a case study. Presented at Tobacco Science Research Conference, 2022.

2021 (3 POSTS)

Lizarraga LE, Patlewicz G, Dean JL II, Zhao QJ, Kaiser JP. 2021. Provisional peer-reviewed toxicity values for 3,4-toluenediamine (CASRN 496-72-0). Cincinnati (OH): U.S. Environmental Protection Agency; 2021 Aug. PMID: 36191119.

O’Neil HC, Vincent MJ, Han AA, Brown SE, Hazell AM, Krieder ML, Madl AM. Hazard and risk banding framework for prioritization and bridging of e-liquids for toxicity testing. Poster presented at Society of Toxicology 60th Annual Meeting, Virtual, March 2021.

View Abstract

Choksi N. Identifying data on your chemical. Continuing Education Course: Rapid Chemical Assessment Using Open Computational Methods, Presented at Society of Toxicology 60th Annual Meeting, Virtual, March 2021.

2020 (3 POSTS)

Bell S, Abedini J, Ceger P, Chang X, Cook B, Karmaus AL, Lea I, Mansouri K, et al. 2020. An integrated chemical environment with tools for chemical safety testing. Toxicol in Vitro 67(Sept):104916; doi: 10.1016/j.tiv.2020.104916.

View Abstract

Pham LL, Borghoff SJ, Thompson CM. 2020. Comparison of threshold of toxicological concern (TTC) values to oral reference dose (RfD) values. Regul Toxicol Pharmacol 113(June):104651; doi: 10.1016/j.yrtph.2020.104651. PMID: 32229245.

View Abstract

Watanabe M, Rogers JM. 2020. Introduction to “The Trouble with Plastics” special issue. Birth Defects Res 112(17):1297–1299; doi: 10.1002/bdr2.1795.

View Abstract

2019 (4 POSTS)

Borghoff S, Fitch S, Britt J, Franke K, Wikoff D. Application of the EFSA/ECHA endocrine disruption guidance as a framework for evidence integration in a weight-of-evidence (WoE) analysis for oxybenzone (BP-3). Poster at Evidence Integration in Chemical Assessments: Challenges Faced in Developing and Communicating Human Health Effect Conclusions. National Academies of Sciences, Engineering, and Medicine, Washington, DC, June 2019.

Lebrun SJ, Choksi N, Daniel A, Allen D, Casey W. Prevalidation of the OptiSafe ocular irritation assay for the detection of ocular corrosives. Poster presented at Society of Toxicology Annual Meeting, Baltimore, MD, March 2019.

View Abstract

Brown L, Forth H, Reichle L, Casner AJ, McFadden A. Using alternatives assessment approaches to inform the ranking of TRI-listed solvent chemicals. Poster presented at Society for Risk Analysis, Arlington, VA, 2019.

Mihalchik-Burhans AL, Sullivan DW. 2019. Bridging issues of route. In: Gad S (ed), Integrated Safety and Risk Assessment for Medical Devices and Combination Products, pp. 273–297. Springer.

View Abstract
Page 1 of 3
123